
Why we do what we do
Empowering research through trusted collaboration.
Purpose: Empowering biotechs to succeed through science, supported by seamless operations.
Mission Statement: BaseBio Consulting delivers clarity and quality in clinical operations. Through experienced oversight and expert vendor selection and management, we help biotechs achieve efficient, transparent, and successful studies in Australia.
Vision Statement: To be recognised as Australia’s leading consultants in clinical operations and vendor oversight — valued for our experience, integrity, and commitment to advancing innovative therapies with excellence.
Values: Innovation, Collaboration, Agility and Integrity
We innovate with purpose, collaborate for meaningful impact, adapt to meet evolving needs, and uphold integrity in every decision and action.

Rachelle Kirk-Burnnand\
Managing Director
Rachelle is a highly experienced clinical trials professional with over 20 years of expertise. She has worked in various roles and organizations, managing global and local clients. Her specialization lies in Early Phase studies, including SAD/MAD, FIH, Biosimilars, Food Effect, and patient cohorts. Rachelle also has extensive experience in Phase II/III studies in multiple therapeutic areas. With strong communication and strategic thinking skills, she excels at working at senior and executive levels. She has a track record of building effective teams, exceeding targets, and managing stakeholder relationships globally. Rachelle is passionate about achieving common goals and delivering results for clients and team members.
Our Team.
Our culture is built on trusted collaboration, purposeful innovation, and a strong delivery mindset. We work as one team with our partners—adapting to evolving needs, making thoughtful decisions, and upholding integrity at every stage. This approach allows us to support clinical programs with clarity, confidence, and care.
Our Expertise
Early Phase, Phase II and Phase III
-
First in Human
-
SAD/MAD
-
BioSimilar
-
Food Effect
-
Oncology
-
Phase I Oncology
-
Neuroscience
-
Mental Health
-
Dermatology
-
DDI (Drug Drug Interactions)
-
Metabolic Disorders
-
Rheumatology
-
Immunology
-
Gastroenterology
-
Vaccines
-
Rare diseases
-
Urology
-
Ophthalmology




